New mouse model shows cannabis smoke triggers specific immune changes in the lungs | Research

The takeaway

A validated mouse model of cannabis smoke exposure showed increased serum cannabinoids and carboxyhaemoglobin, with lung immune changes dominated by macrophage increases rather than neutrophil infiltration, in both male and female mice.

Pulmonary immunology researchers, cannabis smoke exposure investigators, respiratory health scientists

Macrophage increase without neutrophil infiltration distinguishes cannabis from tobacco smoke effects

What the researchers found

Cannabis smoke exposure increased airway and lung tissue macrophage populations (tissue-resident alveolar, monocyte-derived alveolar, and interstitial subtypes) in both sexes. No neutrophil infiltration was observed. Immune mediator analysis showed upregulation of macrophage-derived chemokine, thymus and activation-regulated chemokine, and vascular endothelial growth factor.

Why it matters

The relationship between cannabis smoke and respiratory health remains poorly defined, partly due to lack of validated preclinical models. This accessible model enables systematic investigation of chronic cannabis smoke effects and interactions with respiratory pathogens.

The numbers in context

Mean total particulate matter 698.89 +/- 66.09 ug/L; increased serum cannabinoids and carboxyhaemoglobin confirmed; macrophage populations increased in airways and lung tissue; no neutrophil infiltration; upregulation of MDC, TARC, and VEGF

How the study worked

Male and female BALB/c mice were exposed to cannabis smoke using a commercial exposure system with documented THC/CBD composition. Validated through total particulate matter (mean 698.89 ug/L), serum cannabinoid levels, and carboxyhaemoglobin. Lung cellular responses and immune mediators were characterized by flow cytometry and multiplex analysis.

What this study cannot tell us

Acute exposure model; chronic effects unknown. Mouse respiratory physiology differs from human. Specific cannabis strain and composition may not represent all consumer products. Functional immune outcomes (infection resistance) not tested.

How to read the evidence

Well-validated animal model with rigorous methodology, but limited to acute exposure and a single mouse strain.

When this study was published

Published in 2021.

The bigger picture

The macrophage-dominant immune response (without neutrophil infiltration) distinguishes cannabis smoke from tobacco smoke effects and suggests cannabis may modulate pulmonary immunity through different pathways, with potential implications for infection susceptibility.

Questions still open

Does the macrophage-dominant response protect against or predispose to respiratory infections? How would chronic daily exposure alter these immune profiles? Does the absence of neutrophils mean less tissue damage than tobacco smoke?

Common questions

How is the lung response to cannabis smoke different from tobacco?

Cannabis smoke triggered increases in various macrophage populations but no neutrophil infiltration. Tobacco smoke typically causes both macrophage and neutrophil responses. This suggests cannabis smoke modulates lung immunity through different pathways.

Why does this model matter?

There were few validated preclinical models for studying cannabis smoke effects. This model provides standardized, reproducible exposure conditions with confirmed cannabinoid absorption, enabling systematic research into respiratory health effects.

Read the original research

Development and validation of a mouse model of contemporary cannabis smoke exposure.

ERJ open research, 7(3)

View on PubMed ↗Publisher’s paper ↗

Citation

Fantauzzi, Matthew F; Cass, Steven P; McGrath, Joshua J C; Thayaparan, Danya; Wang, Peiyao; Stampfli, Martin R; Hirota, Jeremy A. (2021). Development and validation of a mouse model of contemporary cannabis smoke exposure.. ERJ open research, 7(3). https://doi.org/10.1183/23120541.00107-2021